Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease.

MLA

Takefumi Kimura, et al. “Thrombospondin 2 Is a Key Determinant of Fibrogenesis in Non-Alcoholic Fatty Liver Disease.” Liver International, vol. 44, no. 2, Feb. 2024, pp. 483–96. EBSCOhost, https://doi.org/10.1111/liv.15792.

APA

Takefumi Kimura, Takanobu Iwadare, Shun-ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, Hamim Zafa, Mai Iwaya, Satoru Joshita, Takeshi Uehara, Sai P. Pydi, Naoki Tanaka, & Takeji Umemura. (2024). Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease. Liver International, 44(2), 483–496. https://doi.org/10.1111/liv.15792

Chicago

Takefumi Kimura, Takanobu Iwadare, Shun-ichi Wakabayashi, Seema Kuldeep, Tomoyuki Nakajima, Tomoo Yamazaki, Daiki Aomura, et al. 2024. “Thrombospondin 2 Is a Key Determinant of Fibrogenesis in Non-Alcoholic Fatty Liver Disease.” Liver International 44 (2): 483–96. doi:10.1111/liv.15792.